【中英雙語閱讀】七夕前夕，六種抗癌新藥獲批上市。（關注本站，每天一篇英文簡報，了解世界，增進知識）

Six new medicines for the treatment of malignant tumors have been approved to enter the Chinese market in the past two years, offering more choices for patients, according to the Department of Major Science and Technology Project of the Ministry of Science and Technology.

中國科學技術部重大科研項目部表示，過去兩年間有6種治療惡性腫瘤的新藥獲批進入國內市場，給了病人更多的選擇。
 
The six new drugs are classified as type-1 medicines in China, which means they are innovative with new structures and new mechanisms and have never previously been marketed either at home or abroad.

這六種新藥在中國被歸類為第一類藥物，這意味著它們具有新結構和新機制的創(chuàng)新，以前從未在國內或國外銷售過。

The newly approved medicines are used for treating malignant tumors such as lung cancer, breast cancer, rectal cancer, melanoma and lymphoma.
 
新批準的藥物用于治療惡性腫瘤，例如肺癌，乳腺癌，直腸癌，黑素瘤和淋巴瘤。
The new anticancer drugs are an outcome of a key science and technology project to develop major new medicines launched in 2008.

新的抗癌藥物是2008年開發(fā)的主要新藥開發(fā)的關鍵科學和技術項目的成果。
Before the start of the project, only five type-1 medicines were approved in China over a period of 23 years, while a total of 44 type-1 medicines have been approved since the launch of the project.

在項目開始之前，中國僅在23年內批準了5種1類藥物，自項目啟動以來，共批準了44種1類藥物。

Chen Kaixian, deputy technical director of the project and an academician of the Chinese Academy of Sciences, said the new medicines have filled the gap of clinical treatment in China, and promoted the reduction of the price of similar drugs in the market, providing affordable drugs and new hope for Chinese patients.

該項目副技術總監(jiān)，中國科學院院士陳開賢表示，新藥填補了中國臨床治療的空白，促進了市場上同類藥物價格的降低，提供了價格合理的藥品。和中國患者的新希望。

必克英語一對一培訓，地道英語學習，
每天只需20分鐘，開啟你的學習之旅
點擊“必克英語一對一課程”
免費領取必克英語試聽課程

【中英雙語閱讀】七夕十二時辰，愿各位安好。

【中英雙語閱讀】8月8日，國內首個夜間動物園正式開放。

【中英雙語閱讀】奧運場館水立方變“冰立方”